Abstract-Bowhead whale (Balaena mysticetus) blubber (n ϭ 20) and plasma (n ϭ 19) samples were collected during the 1997 to 2000 Inuit subsistence harvests in Barrow, Alaska, USA, to quantify the concentrations of methylsulfone (MeSO 2 )-containing and hydroxylated (OH) polychlorinated biphenyl (PCB) metabolites in this cetacean. The distribution of MeSO 2 -PCBs in blubber was dominated by 4-MeSO 2 -substituted congeners, the most abundant being 4-MeSO 2 -CB-70, 3Ј-MeSO 2 -CB-132, and 4-MeSO 2 -CB-64. Mean (Ϯ1 standard error) sum (⌺) MeSO 2 -PCBs concentrations in blubber were low (6.23 Ϯ 0.81 ng g Ϫ1 lipid normalized) compared to concentrations previously reported in other marine mammals. However, similar ratios of MeSO 2 -PCB metabolites to parent PCB congeners among marine mammals suggest that cytochrome P450 2B-like biotransformation and other necessary enzymemediated processes and mechanisms that influence the formation and clearance of MeSO 2 -PCBs exist in the bowhead whale. Pentachlorophenol was the most abundant halogenated phenolic compound quantified in bowhead plasma (1.55 Ϯ 0.19 ng g Ϫ1 wet wt). Despite indirect evidence for arene epoxidation of the biphenyl moiety inferred from MeSO 2 -PCB formation, ⌺OH-PCB concentrations in bowhead plasma were low (1.52 Ϯ 0.31 ng g Ϫ1 wet wt) compared to humans and marine mammals and were comprised of only two detectable OH-PCB congeners (4Ј-OH-CB-130 and 4-OH-CB-187). Further research is required to elucidate the toxicokinetics and distribution of OH-PCBs in this cetacean.
INTRODUCTION
Polychlorinated biphenyls (PCBs) are a well-known class of semivolatile, persistent organochlorine contaminants (OCs) found in virtually every component of the biosphere because of both long-range transport by atmospheric and oceanic vectors and their environmental persistence [1] . The environmental distribution of PCBs is a function of their resistance to abiotic and biotic degradation and hydrophobicity, resulting in their bioaccumulation in the lipid reservoirs of biota. Numerous factors, such as diet, age, and gender, influence the toxicokinetics and accumulation of PCBs in biota [2] . Enzymemediated biotransformation is an important influence on PCB persistence, and its significance in PCB toxicokinetics is dependent on congener structure and the metabolic capacity of the organism [3, 4] . Metabolism of xenobiotics (as a detoxification process) results in the formation of more polar metabolites and, thus, increases the likelihood for elimination from the organism.
Two classes of PCB metabolites have been determined as retained or persistent, namely hydroxylated (OH) and methylsulfone (MeSO 2 )-containing PCBs, respectively. Persistent MeSO 2 -PCBs have been found in the fat and liver tissues of several biota (summarized by Letcher et al. [5] ), and formation is conditional on the capacity of an organism to form 3,4-and/ or 2,3-arene epoxide PCB intermediates, which are intermediates of cytochrome P450 (CYP) isozyme products that are subsequently transformed to MeSO 2 -containing analogues of the parent congeners, mainly by CYP2B-like mediated enzymatic processes [6] . The MeSO 2 -PCBs are sufficiently lipophilic to accumulate in biota and have been linked to endocrine-related effects, including disruption of thyroid hormone homeostasis, cytotoxicity, and competitive binding with the glucocorticoid receptor [5] . Recently, antiestrogenic activity in vitro via a competitive interaction/mechanism with the estrogen receptor was demonstrated for several environmentally relevant MeSO 2 -PCB congeners in several human and fish cell assays [7] .
In contrast to MeSO 2 -PCBs, OH-PCBs have been quantified in the blood of relatively few species, such as humans, seals, and polar bears from Sweden and/or Canada, and recently in various species of Detroit River fish [5, [8] [9] [10] [11] . The introduction of the OH group into the aromatic ring of the parent PCB congener can occur either by direct insertion in the metaposition or by arene epoxide formation and subsequent epoxide hydrolase-mediated ring opening with or without an intermolecular 1,2-shift of H and Cl atoms [12] . Whereas OH-PCBs are subject to further metabolism, their structural similarities to thyroxine result in high affinity and competitive interaction via noncovalent binding with thyroid hormone transport proteins [13] , thereby impeding thyroid hormone and retinol transport and, possibly, impairing hormone metabolism and function [5] .
Our current understanding of PCB biotransformation in some cetaceans has been derived from immunologic and cat-alytic characterization of CYP enzymes, congener-specific accumulation, and extrapolation from mammalian in vitro metabolism models using hepatic microsomes [14] [15] [16] [17] [18] [19] . In general, cetaceans appear to have limited ability for metabolism of nonplanar contaminants via CYP2B-like enzymes, including parent PCB congeners of MeSO 2 -and OH-PCB metabolites, compared to other marine mammals, such as pinnipeds and polar bears [16, 20] . Studies of the concentration and formation of MeSO 2 -PCB metabolites in cetaceans have been limited to a few individuals or species [21] [22] [23] [24] [25] ; however, to our knowledge, the presence of OH-PCBs in any cetacean has not been documented.
The bowhead whale (Balaena mysticetus) is a large mysticete found in the arctic waters of the Bering-Chukchi-Beaufort Seas that primarily feeds on pelagic marine invertebrates [26] . The longevity of this species, its lipid-rich diet, and maintenance of lipid deposits results in the accumulation of lipophilic contaminants [27] . The comparison of PCB congener patterns between bowhead whales and prey suggests a structure-dependent capability of this species to eliminate PCBs [28] . The subsistence hunt of this species by northern Alaskan Inuit communities provides a valuable opportunity to study the accumulation and possible biotransformation of PCBs to potentially toxic and/or biologically active metabolites in apparently healthy cetacean specimens.
MATERIALS AND METHODS

Field sampling
Methodology for the collection of bowhead whale samples has been previously described [29, 30] . Complete bowhead whale blubber cores (n ϭ 20; 10 males and 10 females) and matching plasma samples (n ϭ 19; 9 males and 10 females) were obtained from Inuit subsistence hunters in Barrow, Alaska, USA (71Њ17ЈN, 156Њ45ЈW) through the North Slope Borough Department of Wildlife Management and with approval from the Alaskan Eskimo Whaling Commission in 1997 through 2000. The Department of Wildlife Management personnel recorded the specimen information (i.e., body length, sex, etc.) for each whale landed. Age estimates for the bowhead whales sampled in the present study were not available. However, maturation classification of individual whales was estimated based on body lengths at sexual maturation and known age characteristics (length: female adults, Ͼ13.0-13.5 m; male adults, Ͼ12.5-13.0 m) [31] .
Samples were transported to the National Water Research Institute (Environment Canada, Burlington, ON) with United States (U.S.) export (00US022083/9 and 02US694250/9) and Canadian import (CA02CWIM0052) permits under the Convention on International Trade in Endangered Species and the U.S. Marine Mammal Protection Act (Permit 789-1399; http://www.highnorth.no/Library/Trade/GATTWTO/us-ma-ma. htm). Blubber samples were homogenized and transferred to precleaned glass containers. Whole blood was collected directly into sterile polypropylene plastic screw-top vials (Wheaton Scientific, Millville, NJ, USA) and centrifuged, and the plasma was subsampled. All blubber and plasma samples were stored at Ϫ20ЊC before extraction.
Extraction and quantification of PCBs and MeSO 2 -containing metabolites
The techniques employed for the extraction and analysis of PCBs, MeSO 2 -PCBs, and other OCs in bowhead whale blubber have been described elsewhere [30, 32, 33] . In brief, bowhead whale blubber samples were homogenized with sodium sulfate and spiked with surrogate recovery standards, CB-30 (2,4,6-trichlorobiphenyl), CB-204 (2,2Ј,3,4,4Ј,5,6,6Ј-octachlorobiphenyl), and 3-MeSO 2 -2-CH 3 -2Ј,3Ј,4Ј,5,5Ј-pentachlorobiphenyl (MeSO 2 -ISTD) to monitor analyte recovery. Samples were extracted using n-hexane and dichloromethane (DCM), with lipids and other biogenic materials removed via gel permeation chromatography. The lipid content was determined gravimetrically. Each sample was concentrated and eluted through a 33% potassium hydroxide (KOH)/silica gel column (1.5 g) with 50% DCM:50% n-hexane by volume (v/v) and then concentrated. Each sample was transferred to a Florisil (8 g, 1.2% H 2 O deactivated) column (U.S. Silica, Berkeley Springs, WV, USA) and collected in two fractions. The first fraction (F1) was eluted with 75 ml of DCM:n-hexane and contained PCBs and other OCs. A second fraction (F2), containing MeSO 2 -PCBs, was collected with 80 ml of 7% methanol:93% DCM (v/v). The F2 was passed through a basic alumina column (3.0 g, 2.3% H 2 O deactivated) to remove possible coeluting artifacts and concentrated to 100 l in 2,2,4-trimethylpentane (isooctane).
The F1 eluant (collected above) was chromatographed on 100% activated silica gel into two fractions. The first, containing parent PCB congeners, was collected using 65 ml of 100% n-hexane. The second fraction, containing OC pesticides and by-products, was collected with 95 ml of 50% DCM:50% n-hexane (v/v). Each eluant was fortified in iso-octane and concentrated to 100 l. [30] . Analysis was performed using a Hewlett-Packard (Wilmington, DE, USA) 5890 gas chromatograph (GC) with a 63 Ni-electron capture detector (ECD) [34] . Compound separation was completed using a DB-5 column (60-m length ϫ 0.25-mm internal diameter [i.d.] ϫ 0.25-m internal film thickness [d.f.]; J&W Scientific, Folsom, CA, USA) with H 2 carrier gas, and quantification was performed using a series of multiple external standards that were analyzed after every 10 samples. A standard reference material (SRM1945 adult female pilot whale [Globicephala melaena] blubber homogenate) from the National Institute of Standards and Technology (Gaithersburg, MD, USA) was used to confirm the precision of the analytical method. Analyte concentrations were within 15% of the certified values. The mean recovery (Ϯ1 standard error [SE]) of CB-30 and CB-204 internal standards was 76% Ϯ 3.2% and 86% Ϯ 2.1%, respectively, and concentrations were adjusted accordingly.
The quantification of MeSO 2 -PCB congeners (see Table 1 ) was performed by GC-ECD using previously established methodology [5, 32, 33] . The nomenclature of MeSO 2 -PCBs has been abbreviated and simplified based on the systematic numbering technique applied to PCB congeners [5, 35] . Authentic standards of MeSO 2 -PCBs were used for the quantification of methylsulfone metabolite concentrations, and method detection limits (MDLs) were established as 0.001 ng g Ϫ1 (wet wt). The mean recovery (Ϯ1 SE) of the MeSO 2 -ISTD was 90% Ϯ 3.9% in all samples, and concentrations were subsequently corrected. The SRM1945 was extracted and analyzed concurrently to ascertain the reproducibility of MeSO 2 -PCB data.
Quantification of OH-PCBs and other OCs
Bowhead whale plasma samples (2-9 g) were extracted and analyzed for several PCB congeners (see Table 1 ), OH-PCB metabolites, pentachlorophenol (PCP), and other OC compounds. The total lipid content of plasma samples was determined colorimetrically [11, 36] . Plasma samples were spiked with 4Ј-OH-CB-159 (2,3,3Ј,4,5,5Ј-hexachloro-4Ј-biphenyl), CB-30, and CB-204 internal standards and extracted using established liquid:liquid extraction techniques [8, 9, 11] . In brief, plasma proteins were denatured with 2-propanol and HCl and were extracted with 50% methyl t-butyl ether:50% nhexane (v/v). Samples were concentrated and partitioned with KOH (0.5 M). The neutral and basic compounds (e.g., parent PCBs and other OCs) were separated, eluted through an acidified silica gel column (22% H 2 SO 4 , 3 g) to remove lipids, and fractionated using activated silica gel as described above. Analysis of PCBs and other OCs was performed by GC-ECD [30] .
The partitioned phenolic compounds were acidified, backextracted with methyl t-butyl ether:n-hexane, and derivatized to the methoxylated analogues (MeO-PCBs) using diazomethane before analysis via GC equipped with a mass selective detector in electron capture-negative ionization mode [8, 9] . Compound separation was completed using a HP5-MS column (30-m length ϫ 0.25-mm i.d. ϫ 0.25-m d.f.; Agilent Technologies, Wilmington, DE, USA) with He carrier gas. Quantification of derivatized phenolic compounds was carried out using an authentic standard mixture of 30 halogenated phenolic compounds (HPCs), including methylated OH-PCBs, PCP, and 4-hydroxyheptachlorostyrene. The MDLs for all HPCs analyzed varied from 0.1 to 0.01 ng g Ϫ1 (wet wt). To maintain consistency with other investigations, the nomenclature of OH-PCB and MeO-PCBs was based on the chlorine substitution of the biphenyl moiety and the OH or MeO functional groups numbered thereafter [5] . Mean recoveries (Ϯ1 SE) of the MeO-PCB and neutral PCB internal standards were 75% Ϯ 8.1% and 85% Ϯ 3.5%, respectively, and concentrations were adjusted accordingly.
Data analysis
Statistical analyses were performed using Systat, Version 8.0 (SPSS, Chicago, IL, USA). All hypotheses tested were two-tailed, and the maximum probability of a type I error (␣) was set at 0.05. Initial analysis showed that MeSO 2 -PCB concentrations in blubber were significantly correlated with lipid content (p Ͻ 0.05 for all comparisons, data not shown). As a result, statistical comparisons of PCB and MeSO 2 -PCB concentrations (Table 1) were performed using lipid-normalized (l.w.) concentrations to reduce the variability of lipid content on analyte concentrations [37] .
The pattern of parent PCB congeners and MeSO 2 -PCB metabolites in the bowhead and pilot whale blubber were examined by determining the ratio of individual congener concentrations relative to CB-153. Because of a lack of vicinal H atoms on both biphenyl moieties, 2,2Ј,4,4Ј,5,5Ј-Cl-substituted hexachlorobiphenyl CB-153 is slowly biotransformed or eliminated in cetaceans compared to other PCB congeners [38] . Each parent PCB congener of MeSO 2 -PCB metabolites was assigned to a specific structural group (see Fig. 1 ): PCBs with vicinal meta-para H-atoms and two or fewer ortho chlorines (group IV), congeners with meta-para H atoms with three or more ortho chlorines (group V), and congeners with metapara or ortho-meta H atoms and one ortho Cl atom (group VI) [21, 38] .
The influence of whale body length, sex, parent PCB concentrations, and all first-order effects on MeSO 2 -PCB concentrations in bowhead whale blubber were examined by a general linear model (GLM) to test the hypothesis that male and female bowhead whales have different PCB metabolite concentrations and profiles. A second GLM was also used to investigate influence of ⌺PCB on MeSO 2 -PCB concentration. Whale length and all PCB data were log 10 transformed to reduce the skewness and kurtosis of the raw data and to meet the assumptions for the GLM. All interaction terms were found to be nonsignificant according to type III sums of squares, and the GLM was reduced to where is a constant and ⑀ is the random error component. A simplified GLM was also used to investigate the effect of age (i.e., length cohort) and sex on the ratio of MeSO 2 -PCB congeners to CB-153 concentrations.
The concentrations of OCs, including OH-PCBs and PCP, are reported in Table 2 . Summary statistics were computed only when more than 50% of samples contained detectable concentrations of neutral OCs and HPCs. Values below the established MDL were assigned a random number less than one-half the MDL. Concentrations of OH-PCBs, PCP, parent PCBs, and other OCs were not correlated with plasma lipid content (p Ͼ 0.22 for all comparisons) and are reported on a wet weight basis. The influence of gender and body length on ⌺OC group and individual concentrations in plasma was investigated using a GLM. Plasma OC concentrations and relative proportions were compared to previously published values in bowhead blubber and liver using Model-I, one-way analysis of variance to test the hypothesis that relative proportions of OCs would be equal among these compartments. All a posteriori comparisons among OC groups were explored using Scheffé's test.
RESULTS AND DISCUSSION
MeSO 2 -PCB metabolites in blubber
The bowhead whale is a baleen whale that primarily feeds on marine macroinvertebrates, such as zooplankton [26] . As a result, this species is exposed to, and subsequently accumulates, lower concentrations of persistent OCs than other cetaceans. The mean (Ϯ1 SE) ⌺PCB concentrations in the bowhead whale blubber (451 Ϯ 70 ng g Ϫ1 l.w.) (Table 1) were lower than those found in balaenopterid cetaceans, such as the North Pacific and North Atlantic minke whales (Balaenoptera acutorostrata) [39, 40] . The ⌺PCB in beluga whale blubber (Delphinapterus leucas) from the Alaskan Arctic was significantly greater (mean, 3,305 ng g Ϫ1 l.w.) than in bowhead whales, likely because of the relatively higher trophic status of this odontocete and increased dietary exposure via biomagnification within the marine food web [41] . Reported mean concentrations of ⌺PCB in the Northwest Atlantic right whale were approximately 12 times greater (mean, 5,700 ng g Ϫ1 l.w.) in comparison to concentrations in bowhead whale blubber 197, 180, 193, 191, 199, 170/190, 198, 201, 196/203, 189, 206, 195, 207, 194, 205, 208 , and 209. f Certified value for ⌺PCB (based on 27 congeners) in SRM1945 is approximately 1730 ng g Ϫ1 (l.w.). [17] . Differences in OC concentrations among these cetaceans likely result from the proximity of habitat to local sources of contamination as well as prey selection. The biotransformation of PCB congeners in groups IV to VI, including metabolism of parent congeners of MeSO 2 -PCB metabolites (Fig. 1) , by marine mammals is likely mediated via CYP enzymes with CYP2B-like activity [21, 38] . Attempts have been made to immunologically characterize and measure activities using catalytic bioassays of hepatic CYP isozymes in cetaceans [15, 16, 19] ; however, these properties have not been characterized in the bowhead whale. Nonetheless, biotransformation of PCBs, including parent congeners to MeSO 2 -metabolites, has been inferred from congener profiles relative to PCB concentrations in prey, which are low relative to those of fish-eating birds and other marine mammals [28, 38, 42] . Whereas CYP2B-like gene expression and subsequent isozyme activity in bowhead whales appear to be limited, as-yet-uncharacterized CYP isoenzyme(s) with sufficient catalytic activity may be present and capable of mediating the biotransformation of PCB congeners according to various structural classifications [14, 15, 38, 43] .
The mean (Ϯ1 SE) concentration of ⌺MeSO 2 -PCBs in bowhead whale blubber (6.23 Ϯ 0.81 ng g Ϫ1 l.w.) ( Table 1) was lower than previous measurements in other cetaceans from different marine environments. Total MeSO 2 -PCBs in a single blue whale (Balaenoptera musculus) from Japan was 10 ng g Ϫ1 (l.w.), although individual congeners were not quantified [23] . The sum concentrations of six MeSO 2 -PCB congeners in single blubber samples from a Risso's dolphin (Grampus griseus), common dolphin (Delphinus delphis), pilot whale, and Atlantic white-sided dolphin (Lagenorhynchus acutus) from the Irish Sea ranged between 30 and 580 ng g Ϫ1 (l.w.) [22] . The mean concentration of ⌺MeSO 2 -PCB in male beluga whales from the western Hudson Bay (n ϭ 7) and the St. Lawrence River estuary (Canada) (n ϭ 30) were 159 and 230 ng g Ϫ1 (l.w.), respectively [21] . These interspecies differences in MeSO 2 -PCB concentrations among cetaceans likely result from different dietary exposures to parent PCBs and/or the capacity for CYP-mediated enzymatic biotransformation of parent PCBs and MeSO 2 -PCBs. However, interspecies comparisons must be treated with caution because of the lack of replicates for several species and differences in analytical techniques.
The formation of MeSO 2 -PCB has been reported in deepwater sculpin (Myoxocephalus thompsoni) [44] . We hypothesize that zooplankton and other fish species likely have limited CYP2B-like activity (e.g., [45] ) to biotransform PCBs to persistent metabolites, such as MeSO 2 -PCBs, but the possible contribution of these compounds from dietary sources compared to the proportion derived from cetacean-based CYPmediated biotransformation cannot be adequately assessed by the present study.
The ⌺MeSO 2 -PCB concentrations in the blubber of a stranded adult female pilot whale from the eastern U.S. sea-Environ. Toxicol. Chem. 22, 2003 P.F. Hoekstra et al. board (SRM1945) quantified in the present study (6.47 ng g Ϫ1 l.w.) was lower than previously reported concentrations in this species (210 ng g Ϫ1 l.w.) from the Irish Sea [22] . Whereas the lack of replicates invalidates any statistical comparison to the bowhead whale or other cetaceans, these data provide, to our knowledge, the first report of MeSO 2 -PCB concentrations in a commercially available reference material that can be employed for future quality-control/assurance programs.
The mean ratio of MeSO 2 -PCBs to parent PCB concentrations in bowhead whales (0.10 Ϯ 0.02) was similar to that in other cetaceans and marine mammals. The mean ratio of MeSO 2 -PCBs to the sum concentration of precursor PCB congeners in ringed seal (Phoca hispida) blubber from the Canadian Arctic was approximately 0.034 [33] , whereas the congener-specific ratios in beluga whales from western Hudson Bay ranged between 0.05 and 0.14 [21] . Despite exposure to high concentrations of CYP enzyme-inducing PCB and OCs relative to prey and the presence of immunologically and catalytically determined rat-like CYP2B1 activity, the mean ⌺MeSO 2 -PCB to ⌺PCB ratio in polar bear (Ursus maritimus) adipose tissue was approximately 0.06 [33] . Pinnipeds, odontocetes, and polar bears are regarded as possessing greater CYP2B biotransformation capacity compared to mysticetes [4, 19, 38, 46] . However, the similar ratios suggest that common CYP2B-like metabolic capacities or related mechanisms that influence the formation and clearance of MeSO 2 -PCBs exist among these species.
The mean, congener-specific MeSO 2 -PCB concentrations quantified in bowhead whale blubber were less than 1 ng g Ϫ1 (l.w.) for all compounds. The most abundant congeners, ranked in order from highest to lowest, were 4-MeSO 2 -CB-70, 3Ј-MeSO 2 -CB-132, 4-MeSO 2 -CB-52, 4-MeSO 2 -CB-64, and 4Ј-MeSO 2 -CB-132 and comprised approximately 50% of the ⌺MeSO 2 -PCBs ( Fig. 2 and Table 1 ). The concentrations of ⌺MeSO 2 -PCBs and individual MeSO 2 -PCB congeners in bowhead whale blubber were not significantly influenced by the concentration of parent PCB congeners (GLM, p Ͼ 0.10 for all comparisons). However, the 3-and 4-MeSO 2 -CB-49, -52, -70, -101, -132, -149, and -174 metabolites and ⌺MeSO 2 -PCB concentrations were correlated with increasing ⌺PCB concentrations (Fig. 3) in both male and female bowhead whales (GLM, p Ͻ 0.03 for all comparisons). These data suggest that MeSO 2 -PCB formation increases with PCB exposure or that these metabolites are recalcitrant to further metabolism or excretion and, thus, will accumulate with time in the bowhead whale.
Interactions between congener-specific and ⌺MeSO 2 -PCB concentrations and whale gender and body length were not observed (GLM, p Ͼ 0.15). It was previously observed that PCB concentrations were significantly lower in mature female bowhead whale (i.e., females Ͼ13 m in length) compared to male bowheads from the same length cohort [30] , likely because of the movement of lipophilic contaminants to offspring during lactation and gestation [27] . However, the relatively small sample size for each length cohort limited the statistical power for comparison of MeSO 2 -PCB concentrations by gender.
It should be noted that the predominant MeSO 2 -PCBs in bowhead whale blubber were dissimilar to those found in most other cetaceans (Fig. 2) . In general, 3Ј-and 4Ј-MeSO 2 -CB-101 and 3Ј-MeSO 2 -CB-87 were the most abundant congeners found in common dolphin, Risso's dolphin, white-sided dolphin, pilot whale, and harbor porpoise from the Irish Sea [22] . In male beluga whales from the western Hudson Bay, 3-MeSO 2 -CB-52, 3Ј-MeSO 2 -CB-49, and 4-MeSO 2 -CB-70 were the most abundant congeners, whereas 3Ј-and 4Ј-MeSO 2 -CB-49, -87, and -101 comprised approximately 85% of the ⌺MeSO 2 -PCBs quantified in male belugas from the St. Lawrence River estuary [21] . Variability of MeSO 2 -PCB profile may be caused by differences in PCB exposure and subsequent induction of CYP enzymes that are appropriate catalysts for parent PCB metabolism, age, physiological status, and other factors influencing the PCB metabolism and retention of recalcitrant metabolites.
The relative proportion of MeSO 2 -PCB congeners in bow- e ⌺HCH ϭ sum of hexachlorocyclohexane isomers; ␣-HCH, ␤-HCH, and ␥-HCH. f ⌺PCP ϭ sum of 102 congeners and coelutions (see Table 1 for details). head whale blubber (Fig. 2) is comparable to that in beluga whales from the western Hudson Bay, but the ratios of 3-MeSO 2 -and 4-MeSO 2 -CB-52, -64, and -70 metabolites were reduced (or nondetectable) in beluga whale blubber from the St. Lawrence River estuary stock. Letcher et al. [21] hypothesized that secondary biotransformation of MeSO 2 -PCBs, particularly those with vicinal H atoms in the ortho-meta or metapara positions on the biphenyl moiety, in this beluga population is mediated via the increased induction of CYP1A and/ or CYP2B-like pathways relative to the less contaminated western Hudson Bay stock [21] . Overall, the data imply that CYP-related isozyme activity necessary for secondary MeSO 2 -PCB biotransformation in the bowhead whale is low or negligible and is not induced at current exposure concentrations. The greater abundance of 3-versus 4-MeSO 2 -PCBs in other cetaceans [5] was not observed in bowhead whale blubber. The percentage of 4-substituted MeSO 2 -PCBs to ⌺MeSO 2 -PCB metabolites in odontocetes ranged from 25 to 38% [21, 22, 24] , compared to approximately 60% in bowhead whale blubber. As well, the percentage of 4-MeSO 2 -CB-52 to the sum of 3-and 4-MeSO 2 -CB-52 concentrations in rat liver microsomes was 88%, compared to 38% in mice [47] . The relative abundance of 3-and 4-MeSO 2 -PCB congener pairs could depend on selective formation, accumulation, and/or secondary biotransformation, clearance, and tissue-and protein-specific association of the MeSO 2 -PCB metabolites. In humans, for instance, a greater proportion of 3-MeSO 2 -PCBs (90% of ⌺MeSO 2 -PCBs) was found in liver, whereas 4-substituted MeSO 2 -PCB metabolites (ഠ60%) were selectively accumulated in adipose tissue [48] .
Neutral and OH-PCBs and phenolic OCs
The rank order of ⌺OC in bowhead whale plasma was ⌺PCB Ͼ ⌺CHLOR Ͼ ⌺HCH Ն ⌺ClBz Ͼ ⌺DDT (Table 2) . In general, the relative abundance of ⌺OC in bowhead plasma reflects a combination of the overall proportions observed in liver and blubber (Fig. 4) . No effects of gender and body length on log 10 -transformed, wet weight OC concentrations in plasma were observed (p Ͼ 0.28 for all comparisons). The ⌺PCB, ⌺DDT, and ⌺CHLOR concentrations in blubber generally increased with age in male and subadult female whales (as interpreted by body length) [30] . This interaction likely reflects the time-integrated accumulation of recalcitrant lipophilic contaminants in blubber, whereas the relative abundance of OCs in plasma represents the culmination of recent dietary exposure, biotransformation, and possible remobilization into the circulatory system.
In addition, differences in lipid content and composition may influence OC concentrations and patterns. Lipids in cetacean blubber are predominantly triglycerides, whereas blood contains relatively more polar lipids (e.g., phospholipids), which may result in distinct partitioning of OCs [49] . As well, recent feeding or reproductive activity dramatically influences lipid dynamics in whole blood, including plasma [27] , thereby affecting the relative distribution of OCs compared to other tissues.
The collection of blood samples from marine mammals for OC analysis provides valuable information for health assessment of species for which tissue samples are difficult to obtain [50] . However, our study only quantified OCs in plasma from landed whales and did not address the possible contaminant burden in other hematologic compartments that may serve as important reservoirs for OCs in blood. For example, Boon et al. [51] found that 66% of ⌺PCB in whole blood was associated with erythrocytes, either by sorption to the cellular membrane or by hemoglobin. As a result, a significant proportion of OCs present in the circulatory system may have been omitted from the analysis of bowhead whale plasma alone, and a more detailed research design is required to better describe circulating PCBs and metabolites in this cetacean. The evaluation of OCs in bowhead plasma is further complicated by the fact that contaminant concentrations in cetaceans are typically reported P.F. Hoekstra et al. in other compartments, such as complete blubber cores or biopsy specimens, whole blood (or erythrocytes), liver, and muscle (e.g., [17, 27, 30, 53, 54] ).
Few HPCs were present in bowhead whale plasma at concentrations above the established MDL ( Table 2 ). The most abundant HPC was PCP, which was quantified in all plasma samples extracted. Plasma concentrations of PCP in the bowhead whale were greater than mean concentrations in polar bear and ringed seal plasma (0.210 Ϯ 0.097 and 0.237 Ϯ 0.061 ng g Ϫ1 wet wt, respectively) from the western Canadian Arctic [9] . Pentachlorophenol is a fungicide/insecticide used as a wood preservative, but it is also a possible metabolite of hexachlorobenzene [55] , an abundant environmental contaminant in the Arctic [1] . It is assumed that the PCP concentrations in arctic biota result from the biotransformation of hexachlorobenzene, because PCP does not readily bioaccumulate [56] and has limited potential for long-range transport due to rapid photolysis and reaction with photochemically produced -OH radicals [57] . The relatively high proportion of PCP in bowhead whale plasma may also be the direct result of the biotransformation of pentachloroanisole, an abundant OC contaminant found in arctic air [1] . The metabolism of pentachloroanisole to PCP has been found in other mammalian systems [58, 59] , but this pathway has not been quantified in any cetacean.
The concentrations of ⌺OH-PCBs in bowhead plasma were mainly composed of 4Ј-OH-2,2Ј,3,3Ј,4,5Ј-hexachlorobiphenyl (4Ј-OH-CB-130), which was measurable in approximately 50% of the samples analyzed. The only other OH-PCB quantified at concentrations above the MDL was 4-OH-2,2Ј,3,4Ј,5,5Ј,6-heptachlorobiphenyl (4-OH-CB-187). However, this compound was only observed in a very limited number of samples (4 of 19) . No other OH-PCB congener was detectable above the MDL established in the present study.
Published data regarding OH-PCBs in wildlife are limited. Concentrations in the bowhead whale plasma were relatively low (Table 2 ) compared to mean (Ϯ1 SE) plasma concentrations in other wildlife [5] , including polar bears from the Canadian Arctic (92.6 Ϯ 21.4 ng g Ϫ1 wet wt) [9] . The ⌺OH-PCB concentrations in ringed seal plasma from the Canadian Arctic (0.081 Ϯ 0.019 ng g Ϫ1 wet wt) were lower than those in the bowhead whale [9] and were mainly comprised of 4-OH-CB-187 (ϳ23% of ⌺OH-PCBs; three of five samples analyzed) and two coeluting OH-PCBs, 4-OH-CB-107/4Ј-OH-CB-108 (ϳ9% of ⌺OH-PCBs) (R.J. Norstrom and C.D. Sandau, Environment Canada, Ottawa, ON, personal communication).
The presence of MeSO 2 -PCBs provides indirect evidence for the formation of arene oxide intermediates of PCB congeners, even for highly chlorinated congeners, via Phase I activity, which would suggest that OH-PCBs should be produced in the bowhead whale. However, the lack of significant OH-PCB concentrations in plasma may have been the result of various factors. For example, previous experiments have demonstrated that OH-PCBs have high binding affinities to transthyretin but not toward thyroxin-binding globulin or other thyroid hormone transport proteins [60] . Because the macromolecular content of mysticete blood is not well characterized, possible binding with other proteins, cellular components, or other macromolecules may influence the concentrations of OHPCBs and other OCs in the circulatory system. The Phase II biotransformation of OH-PCBs via conjugation reactions with glucuronic acid or sulfate increases the water solubility of these metabolites and facilitates biliary excretion and/or enterohepatic recycling [61, 62] . However, these pathways for contaminant detoxification in cetaceans have not been assessed. In addition, changes in intravascular blood composition [29] and drug redistribution occur postmortem [63] and may affect the distribution of OH-PCBs in vivo.
Information pertaining to the formation and relative abundance of MeSO 2 -and OH-substituted PCB metabolites is necessary for understanding the toxicodynamics of PCBs in cetaceans and provides valuable data for the health assessment of this species. Contaminant profiles suggest that CYP activity in the bowhead whale is low. However, PCB metabolite data suggest that sufficient CYP2B-like isozyme activity exists in the bowhead whale for the generation of arene epoxide intermediates and subsequent MeSO 2 -PCB formation. The presence of MeSO 2 -PCBs suggests that bowhead whales should have the capacity to form OH-PCB, but the lack of significant concentrations of the latter type of PCB metabolite implies that other factors may influence the accumulation of HPCs in this cetacean. Further research is warranted to adequately address the impact of these (and potentially other) variables on the distribution of OH-PCBs in cetaceans. Additional work is also needed to properly investigate the circulating loads of OCs in cetacean blood, because unlike blubber, such circulating contaminants are readily available to target organs or sites and, thus, are potentially more toxicologically relevant.
